0
Halozyme Therapeutics, Inc. Banner Image

Halozyme Therapeutics, Inc.

  • Ticker HALO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Halozyme Therapeutics, Inc. Logo Image
  • 201-500 Employees
  • Based in San Diego, California
Halozyme Therapeutics is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets. The company's product portfolio is primarily based on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes that affect the extracellular matrix.
REPORT RATINGS
5.0 / 5.0 (1)

Halozyme Therapeutics, Inc. reports have an aggregate usefulness score of 5.0 based on 1 reviews.

Halozyme Therapeutics, Inc.

Most Recent Responsibility Report

Halozyme Therapeutics, Inc.
MOST RECENT 2023 Environmental, Social & Governance Report

Halozyme Therapeutics, Inc. does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Archived Responsibility Reports

Our service enables potential investors to review the most recent and archived Halozyme Therapeutics, Inc. Sustainability Report, Halozyme Therapeutics, Inc. Corporate Social Responsibility Report, Halozyme Therapeutics, Inc. CSR Report, Halozyme Therapeutics, Inc. Corporate Responsibility, Halozyme Therapeutics, Inc. CR Report, Halozyme Therapeutics, Inc. Citizenship Report, Halozyme Therapeutics, Inc. ESG Report, and Halozyme Therapeutics, Inc. Environmental Report online.
Halozyme Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!